Chemical Structure (Methscopolamine 01)
Methscopolamine Bromide Tablet
Product Images NDC 51991-191
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Methscopolamine Bromide (NDC 51991-191). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Breckenridge Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel (2.5 mg Tablet Bottle Label)
This is a description of a medication called Bromide Tablets, which contain 25mg of mehscopolamine biomide. The manufacturer is ILGM Pharma Solutions, and the tablets are distributed by Breckentia Pharmaceuticals. The recommended adult dosage is available on the package insert, and the tablets should be stored in a tight container at room temperature. There are no descriptions of the medication's uses or side effects.*
Principal Display Panel (5 mg Tablet Bottle Label)
Each tablet contains 5mg of methscopolamine bromide and is intended for oral administration. The tablets are distributed by Breckenridge Pharmaceutical, Inc. and the NDC code is 51991-192-06. The tablets should be stored in a tight container according to USP standards within the temperature range of 20°C to 25°C. The usual adult dosage and complete product information can be found in the package insert. There is a warning to keep the tablets out of reach of children. The tablets do not contain lactose. The rest of the text is not readable or not available.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
